We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Troponin T Blood Levels Identify Risk of Death Following Surgery

By LabMedica International staff writers
Posted on 11 Jun 2012
Print article
A simple blood test can help identify people who are at high risk of dying within the month after noncardiac surgery.

The blood test for the level of troponin T can help physicians target patients who need enhanced observation or interventions. Currently, troponin levels are not commonly measured after surgery.

The results are from the VISION study, the largest international prospective study evaluating complications after surgery. VISION enrolled 15,133 adult patients in North and South America, Asia, Australia, and Europe who had a Troponin T measurement daily during the first three days after surgery. Patients were followed in hospital at 30 days after surgery.

"VISION demonstrated that a simple blood test strongly identifies which noncardiac surgery patients are at high risk of dying in the next 30 days," said Dr. P.J. Devereaux, VISION principal investigator; associate professor of medicine, clinical epidemiology and biostatistics of the Michael G. DeGroote School of Medicine at McMaster University (Hamilton, ON, Canada) and cardiologist at Hamilton Health Sciences (Hamilton, ON, Canada).

Devereaux said the results also demonstrated that most patients did not die until an average of six or more days after their Troponin T blood test was identified as elevated. "This holds out great hope that there is time to intervene."

Currently many laboratories consider a Troponin T measurement >0.04 ng/mL abnormal. VISION demonstrated that Troponin T (TnT) values below the commonly used threshold of 0.04 (i.e., 0.02 and 0.03) were strongly associated with 30-day mortality.

More than 200 million adults worldwide have major noncardiac surgery each year. Despite the benefits of surgery, many patients suffer serious complications and more than one million of those patients die within the first 30 days after surgery. Surgery activates pathways of inflammation, stress, and clotting that predispose the heart to injury. As a result, many patients suffer heart attacks after surgery.

The study was published in the June 2012 Journal of the American Medical Association(JAMA).

Related Links:

Michael G. DeGroote School of Medicine at McMaster University
Hamilton Health Sciences


New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Thyroxine ELISA
T4 ELISA
New
Gold Member
Rotavirus Rapid Test
Rotavirus Cassette

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.